Insights

Innovative Antifungal Focus Amplyx specializes in developing first-in-class antifungal treatments targeting life-threatening infections, positioning it as a pioneer in the therapeutic area that appeals to healthcare providers seeking advanced solutions for vulnerable patients.

Recent Acquisition Advantage As a subsidiary of Pfizer, Amplyx benefits from increased credibility, extensive distribution channels, and resource support, creating opportunities for sales partnerships and expanding reach within the pharmaceutical market.

Strong Funding & Growth With over 53 million dollars in recent funding rounds and strategic hires, Amplyx demonstrates financial stability and growth potential, making it a compelling partner for collaborations and investments in innovative medical solutions.

Focused Market Segment Targeting immune-compromised patients with serious fungal infections, Amplyx presents a niche opportunity for specialized healthcare providers and hospitals seeking targeted antifungal therapies.

Emerging Market Presence Operating in the competitive biotech landscape with a focused pipeline, Amplyx offers opportunities to introduce novel antifungal drugs to healthcare organizations looking to expand their infectious disease treatment options.

Amplyx, now a subsidiary of Pfizer Inc. Tech Stack

Amplyx, now a subsidiary of Pfizer Inc. uses 8 technology products and services including MySQL, Google Fonts API, Twemoji, and more. Explore Amplyx, now a subsidiary of Pfizer Inc.'s tech stack below.

  • MySQL
    Database
  • Google Fonts API
    Font Scripts
  • Twemoji
    Font Scripts
  • jQuery Migrate
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Flywheel
    Platform As A Service
  • MediaElement.js
    Video Players
  • Google Analytics
    Web Analytics

Media & News

Amplyx, now a subsidiary of Pfizer Inc.'s Email Address Formats

Amplyx, now a subsidiary of Pfizer Inc. uses at least 1 format(s):
Amplyx, now a subsidiary of Pfizer Inc. Email FormatsExamplePercentage
FLast@amplyx.comJDoe@amplyx.com
76%
First.Last@amplyx.comJohn.Doe@amplyx.com
18%
FirstLast@amplyx.comJohnDoe@amplyx.com
4%
FiLast@amplyx.comJoDoe@amplyx.com
2%

Frequently Asked Questions

Where is Amplyx, now a subsidiary of Pfizer Inc.'s headquarters located?

Minus sign iconPlus sign icon
Amplyx, now a subsidiary of Pfizer Inc.'s main headquarters is located at 12730 High Bluff Drive Suite 160 San Diego, California 92130 United States. The company has employees across 5 continents, including North AmericaAsiaEurope.

What is Amplyx, now a subsidiary of Pfizer Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Amplyx, now a subsidiary of Pfizer Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Amplyx, now a subsidiary of Pfizer Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Amplyx, now a subsidiary of Pfizer Inc.'s official website is amplyx.com and has social profiles on LinkedInCrunchbase.

How much revenue does Amplyx, now a subsidiary of Pfizer Inc. generate?

Minus sign iconPlus sign icon
As of March 2026, Amplyx, now a subsidiary of Pfizer Inc.'s annual revenue is estimated to be $1.7M.

What is Amplyx, now a subsidiary of Pfizer Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Amplyx, now a subsidiary of Pfizer Inc.'s SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Amplyx, now a subsidiary of Pfizer Inc. have currently?

Minus sign iconPlus sign icon
As of March 2026, Amplyx, now a subsidiary of Pfizer Inc. has approximately 17 employees across 5 continents, including North AmericaAsiaEurope. Key team members include Vice President Business Development & Administration: S. D.Senior Vice President Global Marketing: M. P.Product Specialist Biologics: M. C.. Explore Amplyx, now a subsidiary of Pfizer Inc.'s employee directory with LeadIQ.

What industry does Amplyx, now a subsidiary of Pfizer Inc. belong to?

Minus sign iconPlus sign icon
Amplyx, now a subsidiary of Pfizer Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Amplyx, now a subsidiary of Pfizer Inc. use?

Minus sign iconPlus sign icon
Amplyx, now a subsidiary of Pfizer Inc.'s tech stack includes MySQLGoogle Fonts APITwemojijQuery MigratejQueryFlywheelMediaElement.jsGoogle Analytics.

What is Amplyx, now a subsidiary of Pfizer Inc.'s email format?

Minus sign iconPlus sign icon
Amplyx, now a subsidiary of Pfizer Inc.'s email format typically follows the pattern of FLast@amplyx.com. Find more Amplyx, now a subsidiary of Pfizer Inc. email formats with LeadIQ.

How much funding has Amplyx, now a subsidiary of Pfizer Inc. raised to date?

Minus sign iconPlus sign icon
As of March 2026, Amplyx, now a subsidiary of Pfizer Inc. has raised $53M in funding. The last funding round occurred on May 19, 2020 for $53M.

Amplyx, now a subsidiary of Pfizer Inc.

Pharmaceutical ManufacturingCalifornia, United States11-50 Employees

Amplyx was founded on a mission to save lives by developing a new class of antifungal medicine that would overcome the severe limitations of today’s therapeutic options. We are developing first-in-class products for the treatment of life-threatening infections, with a near-term focus on deadly fungal pathogens in vulnerable, immune-compromised patients. Amplyx’s leadership has extensive experience developing drugs to treat infectious diseases, as well as treatments for rare conditions. 

For more information on Amplyx, please visit our website at www.amplyx.com

Section iconCompany Overview

Headquarters
12730 High Bluff Drive Suite 160 San Diego, California 92130 United States
Phone number
Website
amplyx.com
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
11-50

Section iconFunding & Financials

  • $53M

    Amplyx, now a subsidiary of Pfizer Inc. has raised a total of $53M of funding over 9 rounds. Their latest funding round was raised on May 19, 2020 in the amount of $53M.

  • $1M$10M

    Amplyx, now a subsidiary of Pfizer Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $53M

    Amplyx, now a subsidiary of Pfizer Inc. has raised a total of $53M of funding over 9 rounds. Their latest funding round was raised on May 19, 2020 in the amount of $53M.

  • $1M$10M

    Amplyx, now a subsidiary of Pfizer Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.